Bionorica and XO Life: Cooperation enables digital treatment support for women with premenstrual syndrome (PMS) and menstrual cramps

Munich, Germany, 16 July2024 – Bionorica, one of the world's leading manufacturers of scientifically researched herbal medicines, and XO Life, provider of the ImpactMonitor™ platform, are pleased to announce their collaboration. From now on, women who use the herbal medicine Agnucaston® for the relief of premenstrual syndrome (PMS) and menstrual cramps can use the ImpactMonitor™ platform. After registering free of charge on the digital platform and the Bionorica Agnucaston® product area, users receive information about the medicine, health tips, can carry out a cycle check, receive support and track their health status. Registration on the ImpactMonitor™ platform is quick and easy via Mac, PC or the app for iOS and Android.

PMS and menstrual cramps: Millions of women affected

PMS affects around a third of all women of reproductive age. Despite the high prevalence and the considerable impact on quality of life, there is still a lot of catching up to do in terms of research and development of medication and treatment options.

Focus on women's health: making sensible use of digitalisation

Bionorica and XO Life have therefore set themselves the goal of continuously improving the care of women with PMS and menstrual cramps through the possibilities offered by the ImpactMonitor™ platform. The combination of digitalization, dynamic information provision and systematic evaluation of user experiences should make a significant contribution to sustainably improving the medical care and quality of life of affected women. The information can be used as valuable insights for more individualised and optimised patient care in the medical field, in research and in companies. All data collected is treated as strictly confidential and processed in accordance with the highest standards of the General Data Protection Regulation (GDPR).

ImpactMonitor™ platform: digital therapy support for Agnucaston® users

Agnucaston® users can now use the ImpactMonitor™ platform as a valuable addition to their therapy. This platform provides comprehensive information about the female cycle and Agnucaston®. Users can track their cycle and menstrual symptoms, receive tips and document their experiences with herbal therapy and the progression of their menstrual pain.

Cooperation between Bionorica and XO Life: shaping progress

„Die kontinuierliche digitale Therapiebegleitung ist gerade für Frauen von großer Bedeutung, da sie endlich ermöglicht, Real-World-Daten zu erfassen, die direkt in die Behandlungsentscheidungen einbezogen werden. Dadurch wird die Versorgung von Frauen signifikant verbessert. Wir freuen uns, hier Pionierarbeit zu leisten und die Digitalisierung sowie Patienten-Empowerment in der Frauenheilkunde voranzutreiben“, erläutert Dr. Robert Lehner, Marketingleitung Deutschland bei Bionorica.

Dr. Friderike Bruchmann, Co-Founder & CEO of XO Life, adds: "We are delighted to have Bionorica, one of the world's leading manufacturers of scientifically researched herbal medicines, at our side, who is committed to improving healthcare for women. Data is the basis for this and there is far too much patient knowledge that has not yet been incorporated into the research and development of innovative therapies, improved safety of use, interactions with other medicines and much more."

About Bionorica

Bionorica is a global leader in the research and production of herbal medicines. Since its foundation in 1933, the company has focussed on combining traditional herbal medicine with modern scientific research to develop effective and safe herbal medicines. With products in over 40 countries and a focus on gynaecology, respiratory diseases and urinary tract disorders, Bionorica aims to utilise the natural healing powers of plants to improve people's health.

Website: www.bionorica.de

About XO Life

XO Life has created a globally unique meta-platform, the ImpactMonitor™ platform, for digital product and therapy support for patients. Patients are accompanied during their product application or therapy with verified medical and health-relevant content, record their health and therapy progress, receive personalised insights and medical support from experts and can exchange information with other patients. Manufacturers can publish their own product and therapy areas on the ImpactMonitor™ platform and make them available to their patients with their own branding, content, questions and services. By providing personalised information and continuous support during therapies, manufacturers make an important contribution to the success of therapy, therapy adherence and application safety for patients.

XO Life is one of the great beacons of hope in the healthcare sector and is one of the leading digital health start-ups in Germany and Europe. In March 2023, XO Life was nominated for the Digital Award by the Federal Ministry of Economics and Climate Protection as one of 10 start-ups from various sectors of the economy. XO Life works with global market leaders, German pharmaceutical SMEs and orphan drug manufacturers and now offers the ImpactMonitor™ platform in all European countries and languages.

‍

Additional links

Website: www.xo-life.com

LinkedIn: https://www.linkedin.com/company/xo-life

YouTube: https://www.youtube.com/@xo-life/featured